Progression to Metastasis of Solid Cancer

Metastatic dissemination of cancer cells, their colonization at distal sites, and ultimate disruption of tissue physiology are the root causes of most deaths from solid cancers, particularly in tumor types where the primary lesion can be easily dissected and discarded [...].

• Publication year

  2021

• Venue

  Cancers

• Publication date

  2021-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/cancers13040717PMID 33578666PMCID 7916396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy.

  2021cited by this paper
• Fer and FerT Govern Mitochondrial Susceptibility to Metformin and Hypoxic Stress in Colon and Lung Carcinoma Cells

  2021cited by this paper
• SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice

  2021cited by this paper
• Neutrophil: A New Player in Metastatic Cancers

  2020cited by this paper
• ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

  2020cited by this paper
• Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Actin Dynamics

  2020cited by this paper
• Molecular principles of metastasis: a hallmark of cancer revisited

  2020cited by this paper
• Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis

  2020cited by this paper
• Genetic Fate Mapping of Transient Cell Fate Reveals N-Cadherin Activity and Function in Tumor Metastasis.

  2020cited by this paper
• Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets.

  2020cited by this paper
• Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy

  2020cited by this paper
• Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis

  2020cited by this paper
• Roles of mitochondria in the hallmarks of metastasis

  2020cited by this paper
• GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer

  2019cited by this paper
• Defining the Hallmarks of Metastasis.

  2019cited by this paper
• The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact

  2019cited by this paper
• LC3C-Mediated Autophagy Selectively Regulates the Met RTK and HGF-Stimulated Migration and Invasion.

  2019cited by this paper
• Faculty Opinions recommendation of Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance.

  2019influential reference
• Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

  2019cited by this paper
• Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer

  2018cited by this paper
• The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.

  2018cited by this paper
• EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration.

  2018cited by this paper
• A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.

  2018cited by this paper
• Cancer‐Cell‐Intrinsic Mechanisms Shaping the Tumor Immune Landscape

  2018cited by this paper
• TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

  2018cited by this paper
• Atezolizumab and Nab‐Paclitaxel in Advanced Triple‐Negative Breast Cancer

  2018cited by this paper
• New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

  2018influential reference
• Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma

  2018cited by this paper
• A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization.

  2018cited by this paper
• Cyclin D-CDK4 kinase destabilizes PD-L1 via Cul3SPOP to control cancer immune surveillance

  2017cited by this paper
• The RB–IL-6 axis controls self-renewal and endocrine therapy resistance by fine-tuning mitochondrial activity

  2017cited by this paper
• Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.

  2017cited by this paper
• Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis.

  2017cited by this paper
• Integrative Clinical Genomics of Metastatic Cancer

  2017cited by this paper
• STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis.

  2016cited by this paper
• EMT, cell plasticity and metastasis

  2016cited by this paper
• The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE”

  2016cited by this paper
• RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.

  2016cited by this paper
• The Emerging Hallmarks of Cancer Metabolism.

  2016cited by this paper
• Immune cell promotion of metastasis

  2015cited by this paper
• APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation

  2015cited by this paper
• Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression

  2015cited by this paper
• Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA.

  2015cited by this paper
• Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients.

  2015cited by this paper
• PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation to promote metastasis

  2014cited by this paper
• Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

  2014cited by this paper
• Evolution of the cancer stem cell model.

  2014cited by this paper
• Corrigendum: PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis

  2014cited by this paper
• Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα− breast cancer

  2012cited by this paper
• Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

  2012influential reference
• Mitochondrial dynamics regulates migration and invasion of breast cancer cells

  2012cited by this paper
• Regulation of cancer cell metabolism

  2011cited by this paper
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

  2011cited by this paper
• Tumor metastasis: molecular insights and evolving paradigms.

  2011cited by this paper
• Insertional mutagenesis identifies multiple networks of co-operating genes driving intestinal tumorigenesis

  2011cited by this paper
• A pathway-based classification of human breast cancer

  2010cited by this paper
• Distinct biological roles for the akt family in mammary tumor progression.

  2010cited by this paper
• The first 30 years of p53: growing ever more complex

  2009cited by this paper
• Parallel progression of primary tumours and metastases

  2009cited by this paper
• Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression.

  2009cited by this paper
• Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype

  2008cited by this paper
• Systemic spread is an early step in breast cancer.

  2008cited by this paper
• Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors

  2007cited by this paper
• RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.

  2005cited by this paper
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• Dynamics of mitochondrial morphology in healthy cells and during apoptosis

  2003cited by this paper
• Metastasis genes: A progression puzzle

  2002cited by this paper
• A progression puzzle.

  2002cited by this paper
• A mutator phenotype in cancer.

  2001cited by this paper
• Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer

  1999cited by this paper
• Evolution of Cancer

  1991cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells

  1987cited by this paper
• Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture

  1983cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper

• Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities

  2025cites this paper
• Targeting inflammation-driven tumor progression with Zafirlukast via modulation of Jagged-1/Notch-1/Hes-1, Wnt-4/β-catenin, and VEGF signaling pathways in mice

  2025cites this paper
• Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRASmut/P53mut Lung Cancer Cells by Inhibiting c-FLIP

  2024cites this paper
• Thinking (Metastasis) outside the (Primary Tumor) Box

  2023influential citation
• Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer

  2023cites this paper
• Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies

  2023cites this paper
• CDK4/6 inhibitors and the pRB-E2F1 axis suppress PVR and PD-L1 expression in triple-negative breast cancer

  2023cites this paper
• Modeling the Role of Cancer-Associated Fibroblasts in Tumor Cell Invasion

  2022cites this paper
• Diallyl trisulfide inhibits the metastasis of anaplastic thyroid carcinoma cells by targeting TGF-β-Smad3-integrin α2β1 signaling pathway

  2022cites this paper
• Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer

  2022cites this paper